Jaris Computational Biology Centre has set a new standard in computational biology, by reshaping the scientific research ...

Schrödinger shares rise as they announce a research partnership and licensing agreement with Novartis AG. Schrödinger will ...

About iMetabolic Biopharma Corporation iMetabolic Biopharma Corporation (iMBP) is an innovative early-stage TechBio company ...

Google DeepMind releases AlphaFold 3's source code to academics, marking a significant advance in AI-powered molecular biology and drug discovery, while balancing open science with commercial ...

Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.

The companies also have an expanded three-year software agreement that will increase access for Novartis to Schrödinger’s ...

Researchers developed MassiveFold, an enhanced AlphaFold version optimized for parallel processing, which accelerates protein ...

The process of identifying promising small molecule drug candidates that target cancer checkpoints ... The researchers used a ...

Schrödinger, Inc. is a company at the forefront of molecular discovery, utilizing its advanced computational platform for drug development and materials design, primarily serving the biotechnology and ...

Schrodinger (SDGR) today announced a research collaboration and license agreement with Novartis (NVS) to advance multiple development ...

Completely artificial proteins that produce bioluminescence can serve as a non-invasive method for bioimaging, diagnostics, drug discovery, and more.